ScholarIQanswers from OpenAlex

82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges

PaperCitations, authors & open-access status

82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges have?

ScholarIQcitation count

82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges has 2 citations in the OpenAlex counts ScholarIQ stores.

When was 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges published?

ScholarIQyear

82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges has 2023 year in the ScholarIQ index.

What is the open-access status of 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges?

ScholarIQoa status

82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges has closed oa status in the ScholarIQ index.

What is the DOI of 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges?

ScholarIQdoi

The DOI for 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges is on the source record.

What is the OpenAlex record for 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges?

ScholarIQopenalex

The OpenAlex for 82: Teduglutide in 19 pediatric SBS patients – single center real world data on clinical efficacy and treatment associated challenges is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial